A metabolic–inflammatory burden phenotype associated with urinary glucose in colorectal cancer

Background Metabolic dysregulation and chronic inflammation are frequently observed in individuals with colorectal cancer (CRC), particularly in the context of diabetes-related conditions. Identifying simple clinical indicators that reflect these combined alterations remains of interest. Urinary glucose, routinely assessed in clinical practice, may capture transient metabolic stress, but its association with integrated metabolic–inflammatory characteristics in CRC has not been systematically evaluated. Methods A hospital-based cross-sectional case–control analysis was conducted, including individuals with confirmed colorectal cancer (CRC) and non-CRC controls undergoing clinical evaluation during the same period. A composite Metabolic–Inflammatory Burden Score (MIBS) was constructed using urinary glucose status together with selected inflammatory and tumor markers. Multivariable logistic regression was performed with CRC status (1 = CRC, 0 = non-CRC) as the dependent variable, and model performance was assessed in the primary cohort. External validation was performed in an independent NHANES subset using a reduced model consistent with the variables available in that dataset. Results Individuals with higher urinary glucose categories exhibited higher levels of systemic inflammation and tumor-related markers, along with altered immune cell profiles. Urinary glucose remained associated with CRC after adjustment for demographic, metabolic, inflammatory, and molecular factors. Incorporation of urinary glucose into the composite framework was associated with improved model discrimination in the primary analysis, and similar patterns were observed in the external NHANES cohort, including differences in predicted risk distributions across urinary glucose categories. Conclusion Urinary glucose was associated with distinct metabolic–inflammatory characteristics in CRC and contributed to a composite burden framework that demonstrated consistent patterns in an independent population-based dataset.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-03-13
DOI
https://doi.org/10.3389/fcell.2026.1797508
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A metabolic–inflammatory burden phenotype associated with urinary glucose in colorectal cancer

Zhe Deng, Qiuyan Guan, Hao Wang, Ningzhe Yan et al.
Frontiers in Cell and Developmental Biology
Inflammatory Biomarkers in Disease Prognosis
article

A metabolic–inflammatory burden phenotype associated with urinary glucose in colorectal cancer

Zhe Deng, Qiuyan Guan, Hao Wang, Ningzhe Yan, W Q Yan, Jie Li
article en

Abstract

Background Metabolic dysregulation and chronic inflammation are frequently observed in individuals with colorectal cancer (CRC), particularly in the context of diabetes-related conditions. Identifying simple clinical indicators that reflect these combined alterations remains of interest. Urinary glucose, routinely assessed in clinical practice, may capture transient metabolic stress, but its association with integrated metabolic–inflammatory characteristics in CRC has not been systematically evaluated. Methods A hospital-based cross-sectional case–control analysis was conducted, including individuals with confirmed colorectal cancer (CRC) and non-CRC controls undergoing clinical evaluation during the same period. A composite Metabolic–Inflammatory Burden Score (MIBS) was constructed using urinary glucose status together with selected inflammatory and tumor markers. Multivariable logistic regression was performed with CRC status (1 = CRC, 0 = non-CRC) as the dependent variable, and model performance was assessed in the primary cohort. External validation was performed in an independent NHANES subset using a reduced model consistent with the variables available in that dataset. Results Individuals with higher urinary glucose categories exhibited higher levels of systemic inflammation and tumor-related markers, along with altered immune cell profiles. Urinary glucose remained associated with CRC after adjustment for demographic, metabolic, inflammatory, and molecular factors. Incorporation of urinary glucose into the composite framework was associated with improved model discrimination in the primary analysis, and similar patterns were observed in the external NHANES cohort, including differences in predicted risk distributions across urinary glucose categories. Conclusion Urinary glucose was associated with distinct metabolic–inflammatory characteristics in CRC and contributed to a composite burden framework that demonstrated consistent patterns in an independent population-based dataset.

Frontiers in Cell and Developmental BiologyVol. 14
Beijing University of Chinese Medicine (CN), Shandong Provincial Hospital (CN), China Academy of Chinese Medical Sciences (CN), Guang’anmen Hospital (CN), Shandong First Medical University (CN)
China Academy of Chinese Medical Sciences
Reduced inequalities, Peace, Justice and strong institutions
Openalex Percentile: Top 23%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.